Famotidine

NDC 63323-739 · Fresenius Kabi USA, LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameFamotidine

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)FAMOTIDINE

Strength10 mg/mL

Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

63323-739-16 — 25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41)

63323-739-12 — 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-739-12) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-739-11)

J1308 — Injection, famotidine, 0.25 mg Medicare Part B payment limit (ASP + 6%): $0.01

FDA lists these products with the same active ingredient.

61442-122 — Famotidine, 62135-807 — famotidine, 62135-808 — famotidine, 62332-001 — Famotidine, 62332-002 — Famotidine, 63187-129 — Famotidine, 63187-723 — Famotidine, 63187-908 — Famotidine, 63187-999 — Famotidine, 63323-738 — FAMOTIDINE, 63629-2014 — Famotidine, 63629-2015 — Famotidine, 63629-2782 — Famotidine, 63629-7013 — Famotidine, 63629-8891 — Ibuprofen and famotidine, 63868-583 — Famotidine, 63868-584 — Famotidine, 63941-009 — Famotidine, 63941-011 — Famotidine, 63981-194 — Famotidine, +401 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.